# Tempest Therapeutics, Inc.: filings

TPST · Nasdaq · CIK 1544227 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tpst.md) · [Financials](/companies/tpst/financials.md) · [Filings](/companies/tpst/filings.md) · [Insiders](/companies/tpst/insiders.md)

## Reports and events: 303 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 369, 8-K 180, 3 72, SC 13G/A 44, 10-Q 43, 424B3 30, SC 13D/A 26, SC 13G 26, DEFA14A 23, EFFECT 21, S-8 20, DEF 14A 16, 424B5 15, CORRESP 15, UPLOAD 15, 10-K 14, S-3 13, SC 13D 9, CT ORDER 8, 425 7, D 7, PRE 14A 6, S-8 POS 6, 4/A 5, ARS 5, S-1 4, S-3/A 4, S-4/A 4, SCHEDULE 13D/A 4, 10-12G/A 3, 10-K/A 3, 144 3, D/A 3, POS AM 3, 8-A12B 2, 8-K/A 2, S-4 2, 10-12G 1, 424B2 1, 8-A12B/A 1, CERTNAS 1, DEFM14A 1, RW 1, S-1/A 1, SCHEDULE 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:05 ET | [8-K](/filings/0001213900-26-114376.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-114376 |
| 2026-10-26 | 16:05 ET | [DEF 14A](/filings/0001213900-26-112476.md) | Proxy statement, period 2026-11-09 | 0001213900-26-112476 |
| 2026-10-20 | 16:06 ET | [8-K](/filings/0001213900-26-111026.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001213900-26-111026 |
| 2026-10-19 | 16:05 ET | [8-K](/filings/0001213900-26-110669.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-110669 |
| 2026-09-28 | 16:05 ET | [8-K](/filings/0001213900-26-104034.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-104034 |
| 2026-09-17 | 17:05 ET | [8-K](/filings/0001193125-26-394492.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-394492 |
| 2026-09-16 | 16:37 ET | [8-K](/filings/0001193125-26-393151.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-26-393151 |
| 2026-09-15 | 16:06 ET | [8-K](/filings/0001193125-26-391903.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-391903 |
| 2026-08-24 | 16:43 ET | [8-K](/filings/0001193125-26-363695.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-363695 |
| 2026-08-21 | 16:46 ET | [S-1](/filings/0001193125-26-361240.md) | Registration statement | 0001193125-26-361240 |
| 2026-08-18 | 16:27 ET | [8-K](/filings/0001193125-26-355550.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-26-355550 |
| 2026-08-13 | 16:37 ET | [10-Q](/filings/0001193125-26-349381.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349381 |
| 2026-08-13 | 16:36 ET | [8-K](/filings/0001193125-26-349374.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-349374 |
| 2026-08-13 | 16:31 ET | [8-K](/filings/0001193125-26-349334.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-349334 |
| 2026-07-28 | 16:50 ET | [8-K](/filings/0001193125-26-321176.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-26-321176 |
| 2026-07-22 | 16:05 ET | [8-K](/filings/0001193125-26-312391.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-312391 |
| 2026-07-17 | 16:32 ET | [DEF 14A](/filings/0001140361-26-028823.md) | Proxy statement, period 2026-07-27 | 0001140361-26-028823 |
| 2026-06-23 | 20:22 ET | [8-K](/filings/0001193125-26-278068.md) | 5.07 Shareholder vote results | 0001193125-26-278068 |
| 2026-06-08 | 16:06 ET | [DEF 14A](/filings/0001140361-26-024453.md) | Proxy statement, period 2026-06-18 | 0001140361-26-024453 |
| 2026-06-04 | 17:00 ET | [8-K](/filings/0001193125-26-257684.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-257684 |
| 2026-06-02 | 19:13 ET | [8-K](/filings/0001193125-26-251994.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-251994 |
| 2026-05-29 | 17:01 ET | [8-K](/filings/0001193125-26-248648.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-248648 |
| 2026-05-22 | 17:28 ET | [8-K](/filings/0001193125-26-237207.md) | 3.01 Delisting notice | 0001193125-26-237207 |
| 2026-05-22 | 17:05 ET | [8-K](/filings/0001193125-26-237150.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-237150 |
| 2026-05-14 | 17:03 ET | [10-Q](/filings/0001193125-26-224289.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224289 |
| 2026-05-14 | 16:28 ET | [8-K](/filings/0001193125-26-224156.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-224156 |
| 2026-05-06 | 07:45 ET | [8-K](/filings/0001193125-26-207601.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-207601 |
| 2026-04-02 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001193125-26-140271.md) | Ownership report, active investor, amended | 0001193125-26-140271 |
| 2026-03-30 | 08:35 ET | [10-K](/filings/0001193125-26-130490.md) | Annual report, period 2025-12-31 | 0001193125-26-130490 |
| 2026-03-30 | 08:28 ET | [8-K](/filings/0001193125-26-130480.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-130480 |
| 2026-03-25 | 17:33 ET | [SCHEDULE 13D/A](/filings/0001931356-26-000013.md) | Ownership report, active investor, amended | 0001931356-26-000013 |
| 2026-03-23 | 08:17 ET | [8-K](/filings/0001193125-26-118618.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-118618 |
| 2026-02-25 | 08:09 ET | [8-K](/filings/0001193125-26-068614.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-068614 |
| 2026-02-11 | 07:14 ET | [8-K](/filings/0001193125-26-045543.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-045543 |
| 2026-02-10 | 17:15 ET | [SCHEDULE 13D](/filings/0001931356-26-000009.md) | Ownership report, active investor | 0001931356-26-000009 |
| 2026-02-06 | 16:12 ET | [8-K](/filings/0001193125-26-041190.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-041190 |
| 2026-01-28 | 16:05 ET | [8-K](/filings/0001193125-26-027203.md) | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-027203 |
| 2026-01-09 | 16:15 ET | [8-K](/filings/0001193125-26-008938.md) | 3.01 Delisting notice | 0001193125-26-008938 |
| 2025-12-31 | 16:15 ET | [DEF 14A](/filings/0001140361-25-047054.md) | Proxy statement, period 2026-01-27 | 0001140361-25-047054 |
| 2025-12-09 | 16:51 ET | [S-1](/filings/0001193125-25-312887.md) | Registration statement | 0001193125-25-312887 |
| 2025-11-26 | 08:55 ET | [8-K](/filings/0001193125-25-298604.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-298604 |
| 2025-11-19 | 09:16 ET | [8-K](/filings/0001193125-25-287163.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-287163 |
| 2025-11-05 | 09:12 ET | [10-Q](/filings/0001193125-25-265946.md) | Quarterly report, period 2025-09-30 | 0001193125-25-265946 |
| 2025-11-05 | 09:04 ET | [8-K](/filings/0001193125-25-265937.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265937 |
| 2025-08-13 | 19:14 ET | [SCHEDULE 13D/A](/filings/0000950170-25-108261.md) | Ownership report, active investor, amended | 0000950170-25-108261 |
| 2025-08-11 | 16:13 ET | [10-Q](/filings/0000950170-25-106558.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106558 |
| 2025-08-11 | 16:07 ET | [8-K](/filings/0000950170-25-106544.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106544 |
| 2025-06-12 | 16:18 ET | [8-K](/filings/0001193125-25-139899.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-139899 |
| 2025-06-11 | 07:41 ET | [8-K](/filings/0001193125-25-138802.md) | 8.01 Other events | 0001193125-25-138802 |
| 2025-06-06 | 16:05 ET | [8-K](/filings/0001193125-25-137041.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-137041 |

Page 1 of 7. [Older](/companies/tpst/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:12 ET. No prices; not investment advice.